Cargando…

Evaluation of a Lipopolysaccharide and Resiquimod Combination as an Adjuvant with Inactivated Newcastle Disease Virus Vaccine in Chickens

Various toll-like receptor (TLR) agonists have shown potential as adjuvants with different vaccines in both human and livestock species, including chickens. Our previous studies on combination of lipopolysaccharide (LPS; TLR4 agonist) and resiquimod (R-848; TLR7 agonist) showed the synergistic up-re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Bal Krishnan, Ramakrishan, Saravanan, Kaliappan, Abinaya, Singh, Mithilesh, Kumar, Ajay, Dandapat, Satyabrata, Dey, Sohini, Chellappa, Madhan Mohan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229813/ https://www.ncbi.nlm.nih.gov/pubmed/35746503 http://dx.doi.org/10.3390/vaccines10060894

Ejemplares similares

Resiquimod enhances mucosal and systemic immunity against avian infectious bronchitis virus vaccine in the chicken
por: Matoo, Javaid Jeelani, et al.
Publicado: (2018)

Newcastle Disease Virus Vectored Bivalent Vaccine against Virulent Infectious Bursal Disease and Newcastle Disease of Chickens
por: Dey, Sohini, et al.
Publicado: (2017)

Newcastle Disease Virus Vectored Chicken Infectious Anaemia Vaccine Induces Robust Immune Response in Chickens
por: Chellappa, Madhan Mohan, et al.
Publicado: (2021)

Genotype Characterization of Commonly Used Newcastle Disease Virus Vaccine Strains of India
por: Dey, Sohini, et al.
Publicado: (2014)

Immunogenicity and protective efficacy of an inactivated Newcastle disease virus vaccine encapsulated in poly-(lactic-co-glycolic acid) nanoparticles
por: Ananda Kumar, B.S., et al.
Publicado: (2023)

Complete Genome Sequence of a Newcastle Disease Virus Isolated from Wild Peacock (Pavo cristatus) in India
por: Khulape, Sagar A., et al.
Publicado: (2014)

Recombinant Newcastle Disease Virus (NDV) Expressing Sigma C Protein of Avian Reovirus (ARV) Protects against Both ARV and NDV in Chickens
por: Saikia, Deep Prakash, et al.
Publicado: (2019)

Topically Applied Resiquimod versus Imiquimod as a Potential Adjuvant in Melanoma Treatment
por: Tambunlertchai, Supreeda, et al.
Publicado: (2022)

Resiquimod and polyinosinic–polycytidylic acid formulation with aluminum hydroxide as an adjuvant for foot-and-mouth disease vaccine
por: Zhou, Chun-Xue, et al.
Publicado: (2014)

Infectious bursal disease virus in chickens: prevalence, impact, and management strategies
por: Dey, Sohini, et al.
Publicado: (2019)

A Squalene-Based Nanoemulsion for Therapeutic Delivery of Resiquimod
por: Zhang, Zhongkun, et al.
Publicado: (2021)

Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma
por: Sabado, Rachel L, et al.
Publicado: (2013)

Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer
por: Pauli, Griffin, et al.
Publicado: (2021)

Combination of TLR2 and TLR3 agonists derepress infectious bursal disease virus vaccine-induced immunosuppression in the chicken
por: Bashir, Khalid, et al.
Publicado: (2019)

Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple Sclerosis
por: Corsetti, Marta, et al.
Publicado: (2019)

Efficacy of live B1 or Ulster 2C Newcastle disease vaccines simultaneously vaccinated with inactivated oil adjuvant vaccine for protection of Newcastle disease virus in broiler chickens
por: Chansiripornchai, N, et al.
Publicado: (2006)

Comparing the immunogenicity of glycosidase-directed resiquimod prodrugs mediated by cancer cell metabolism
por: Ryan, Austin T, et al.
Publicado: (2020)

Protective efficacy of inactivated Newcastle disease virus vaccines prepared in two different oil-based adjuvants
por: Aljumaili, Oday A., et al.
Publicado: (2020)

Serological profiling of rabies antibodies by enzyme-linked immunosorbent assay and its comparative analysis with rapid fluorescent focus inhibition test in mouse model
por: Debnath, Ashis, et al.
Publicado: (2019)

Assessment of in vitro potency of inactivated Newcastle disease oil-adjuvanted vaccines using hemagglutination test and blocking ELISA
por: Aly, Saleh E., et al.
Publicado: (2018)

Dual-Functional PLGA Nanoparticles Co-Loaded with Indocyanine Green and Resiquimod for Prostate Cancer Treatment
por: Lin, Wenfeng, et al.
Publicado: (2021)

Adjuvant Activity of Sargassum pallidum Polysaccharides against Combined Newcastle Disease, Infectious Bronchitis and Avian Influenza Inactivated Vaccines
por: Li, Li-Jie, et al.
Publicado: (2012)

Efficacy of inactivated velogenic Newcastle disease virus genotype VII vaccine in broiler chickens
por: Fawzy, Mohamed, et al.
Publicado: (2020)

Combination of Radiofrequency Ablation With Resiquimod to Treat Hepatocellular Carcinoma Via Inflammation of Tumor Immune Microenvironment and Suppression of Angiogenesis
por: Tian, Zhou, et al.
Publicado: (2022)

Effects of Bacillus subtilis Natto Strains on Antiviral Responses in Resiquimod-Stimulated Human M1-Phenotype Macrophages
por: Fujii, Keisuke, et al.
Publicado: (2023)

Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity
por: Anfray, Clément, et al.
Publicado: (2021)

Systemic Administration of the TLR7/8 Agonist Resiquimod (R848) to Mice Is Associated with Transient, In Vivo-Detectable Brain Swelling
por: Zahr, Natalie May, et al.
Publicado: (2022)

NMR Structure of Temporin-1 Ta in Lipopolysaccharide Micelles: Mechanistic Insight into Inactivation by Outer Membrane
por: Saravanan, Rathi, et al.
Publicado: (2013)

THE PROPERDIN SYSTEM AND IMMUNITY : VI. THE INACTIVATION OF NEWCASTLE DISEASE VIRUS BY THE PROPERDIN SYSTEM
por: Wedgwood, Ralph J., et al.
Publicado: (1956)

Inactivation Efficacy of Nonthermal Plasma-Activated Solutions against Newcastle Disease Virus
por: Su, Xia, et al.
Publicado: (2018)

Complete Genome Sequence of a Virulent Duck Enteritis Virus (DEV/India/IVRI-2016) Isolated from Southern India
por: Dandapat, Satyabrata, et al.
Publicado: (2022)

In-vitro Modulation of mTOR-HIF-1α Axis by TLR7/8 Agonist (Resiquimod) in B-Chronic Lymphocytic Leukemia
por: Hanafy, Rana M., et al.
Publicado: (2023)

Protective efficacy of commercial inactivated Newcastle disease virus vaccines in chickens against a recent Korean epizootic strain
por: Jeon, Woo-Jin, et al.
Publicado: (2008)

Enhancement in humoral response against inactivated Newcastle disease vaccine in broiler chickens administered orally with plant-derived soyasaponin
por: Naveed, Ghania, et al.
Publicado: (2020)

Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes
por: Firouzamandi, Masoumeh, et al.
Publicado: (2016)

In Ovo Delivered Toll-Like Receptor 7 Ligand, Resiquimod Enhances Host Responses against Infectious Bronchitis Corona Virus (IBV) Infection
por: De Silva Senapathi, Upasama, et al.
Publicado: (2020)

Fludarabine as an Adjuvant Improves Newcastle Disease Virus-Mediated Antitumor Immunity in Hepatocellular Carcinoma
por: Meng, Gang, et al.
Publicado: (2019)

CAvant® WO-60 as an Effective Immunological Adjuvant for Avian Influenza and Newcastle Disease Vaccine
por: Lee, Eun-Seo, et al.
Publicado: (2021)

Inactivated poultry plague vaccine from virus Newcastle disease culture in incubated hen egg
Publicado: (1986)

Preparation of the inactivated Newcastle disease vaccine by plasma activated water and evaluation of its protection efficacy
por: Hongzhuan, Zhou, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pvbboonsiev9ohqfng8vea4opt